DD159737A5 - Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen - Google Patents

Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen Download PDF

Info

Publication number
DD159737A5
DD159737A5 DD81231010A DD23101081A DD159737A5 DD 159737 A5 DD159737 A5 DD 159737A5 DD 81231010 A DD81231010 A DD 81231010A DD 23101081 A DD23101081 A DD 23101081A DD 159737 A5 DD159737 A5 DD 159737A5
Authority
DD
German Democratic Republic
Prior art keywords
vincamine
preparations
salt
item
cation exchange
Prior art date
Application number
DD81231010A
Other languages
German (de)
English (en)
Inventor
Satish C Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD159737A5 publication Critical patent/DD159737A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
DD81231010A 1980-06-23 1981-06-22 Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen DD159737A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH480480 1980-06-23

Publications (1)

Publication Number Publication Date
DD159737A5 true DD159737A5 (de) 1983-04-06

Family

ID=4282830

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81231010A DD159737A5 (de) 1980-06-23 1981-06-22 Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen

Country Status (15)

Country Link
EP (1) EP0042818A1 (ko)
JP (1) JPS5762277A (ko)
KR (1) KR830005853A (ko)
AU (1) AU7201781A (ko)
DD (1) DD159737A5 (ko)
DK (1) DK274081A (ko)
ES (1) ES8203891A1 (ko)
FI (1) FI811934L (ko)
GB (1) GB2078758A (ko)
GR (1) GR75708B (ko)
IL (1) IL63148A0 (ko)
NO (1) NO812039L (ko)
NZ (1) NZ197485A (ko)
PT (1) PT73238B (ko)
ZA (1) ZA814194B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (ko) * 1955-08-08
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
PT66201B (fr) * 1976-02-23 1978-11-07 Corvi Mora E Procede et composition pour la therapeutique des maladies circulatoires cerebrales

Also Published As

Publication number Publication date
DK274081A (da) 1981-12-24
GR75708B (ko) 1984-08-02
ES503263A0 (es) 1982-04-01
NO812039L (no) 1981-12-28
JPS5762277A (en) 1982-04-15
KR830005853A (ko) 1983-09-14
NZ197485A (en) 1983-09-30
IL63148A0 (en) 1981-09-13
EP0042818A1 (de) 1981-12-30
ES8203891A1 (es) 1982-04-01
PT73238B (de) 1983-05-11
AU7201781A (en) 1982-01-07
ZA814194B (en) 1982-07-28
FI811934L (fi) 1981-12-24
PT73238A (de) 1981-07-01
GB2078758A (en) 1982-01-13

Similar Documents

Publication Publication Date Title
EP1390023B1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
EP1207868B1 (de) Pharmazeutische tramadolsalze
DE69830728T2 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DD146547A5 (de) Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
EP1435915B1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
DE60202615T2 (de) Kristalline zusammensetzung mit escitalopram
DD201139A5 (de) Verfahren zur herstellung von (-)-n-methyl-3-(2-methylphenoxy)-3-phenylpropylamin und seinen pharmazeutisch unbedenklichen salzen
DD218373A5 (de) Verfahren zur herstellung eines resinates einer substituierten carbonsaeure
EP0386440A1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DD292374A5 (de) Verfahren zum herstellen von ueberzugsmaterialien zur steuerung der arzneimittelfreisetzung bei langzeitwirkenden zubereitungen
DE69919155T2 (de) Formulierungen zur mehrfachfreisetzung
DE1908946A1 (de) Pharmazeutische Praeparate und Verfahren zur Herstellung derselben
EP0167909B1 (de) Feste Arzneizubereitungen mit Dihydropyridin und Verfahren zu ihrer Herstellung
CH634561A5 (de) Verfahren zur herstellung von neuen 1-nitro-9-dialkylaminoisoalkylaminoacridinen.
US4369175A (en) Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them
DD159737A5 (de) Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen
DE2950154C2 (ko)
DE3034975C2 (de) Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE2300614A1 (de) Neue optisch aktive verbindungen
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
DE2220333A1 (de) Pyridinderivate, verfahren zu deren herstellung und deren verwendung
DE602005004033T2 (de) Venlafaxin enthaltende pharmazeutische teilchenförmige zusammensetzung mit verzögerter freisetzung
DE2100269C3 (ko)
DE2362783C2 (de) Pharmazeutisches Kombinationspräparat zur Behandlung von Rhinitis
CH383552A (de) Verfahren zur Herstellung von Harz-Arzneistoffverbindungen